Page last updated: 2024-08-26

8-chloro-cyclic adenosine monophosphate and Leukemia, Myeloid, Acute

8-chloro-cyclic adenosine monophosphate has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldinucci, D; Budillon, A; Cho-Chung, YS; Gattei, V; Pinto, A; Tortora, G; Zagonel, V1

Other Studies

1 other study(ies) available for 8-chloro-cyclic adenosine monophosphate and Leukemia, Myeloid, Acute

ArticleYear
Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Oct-01, Volume: 89, Issue:19

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Affinity Labels; Antigens, Surface; Antineoplastic Agents; Azides; Blast Crisis; Cell Survival; Culture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Kinetics; Leukemia, Myeloid, Acute; Receptors, Cyclic AMP; Tumor Cells, Cultured

1992